Related references
Note: Only part of the references are listed.Revealing the Potential Application of EC-Synthetic Retinoid Analogues in Anticancer Therapy
Mohamed R. Abdelaal et al.
MOLECULES (2021)
SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells
Su-Wei Xu et al.
PHARMACOLOGICAL RESEARCH (2020)
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Karol Bukowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
AAA+ ATPases in Protein Degradation: Structures, Functions and Mechanisms
Shuwen Zhang et al.
BIOMOLECULES (2020)
Structural and functional diversity calls for a new classification of ABC transporters
Christoph Thomas et al.
FEBS LETTERS (2020)
Neurogenesis in Response to Synthetic Retinoids at Different Temporal Scales
Hesham Haffez et al.
MOLECULAR NEUROBIOLOGY (2018)
Probing biological activity through structural modelling of ligand-receptor interactions of 2,4-disubstituted thiazole retinoids
Hesham Haffez et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
The challenge of drug resistance in cancer treatment: a current overview
Michail Nikolaou et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
The therapeutic potential of targeting ABC transporters to combat multi-drug resistance
Piyush Bugde et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
The molecular basis of the interactions between synthetic retinoic acid analogues and the retinoic acid receptors
Hesham Haffez et al.
MEDCHEMCOMM (2017)
Interactions of retinoids with the ABC transporters P-glycoprotein and Breast Cancer Resistance Protein
Szabolcs Tarapcsak et al.
SCIENTIFIC REPORTS (2017)
Allocrite Sensing and Binding by the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1)
Yanyan Xu et al.
BIOCHEMISTRY (2015)
Retinoic acid receptors: From molecular mechanisms to cancer therapy
Alessandra di Masi et al.
MOLECULAR ASPECTS OF MEDICINE (2015)
Predicting Activators and Inhibitors of the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1) Based on Mechanistic Considerations
Estefania Egido et al.
MOLECULAR PHARMACEUTICS (2015)
Refined structures of mouse P-glycoprotein
Jingzhi Li et al.
PROTEIN SCIENCE (2014)
Effect of 9-cis retinoic acid and all-trans retinoic acid in combination with verapamil on P-glycoprotein expression in L1210 cells
A. Breier et al.
NEOPLASMA (2014)
A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway
Bei Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2013)
Adaptive Dosing Approaches to the Individualization of 13-Cis-Retinoic Acid (Isotretinoin) Treatment for Children with High-Risk Neuroblastoma
Gareth J. Veal et al.
CLINICAL CANCER RESEARCH (2013)
P-Glycoprotein-ATPase Modulation: The Molecular Mechanisms
Xiaochun Li-Blatter et al.
BIOPHYSICAL JOURNAL (2012)
A sensitive and specific method for measurement of multiple retinoids in human serum with UHPLC-MS/MS
Samuel L. M. Arnold et al.
JOURNAL OF LIPID RESEARCH (2012)
Placental drug transporters and their role in fetal protection
M. Iqbal et al.
PLACENTA (2012)
PKD2 mediates multi-drug resistance in breast cancer cells through modulation of P-glycoprotein expression
Jiao Chen et al.
CANCER LETTERS (2011)
Synergistic Activity of Fenretinide and the Bcl-2 Family Protein Inhibitor ABT-737 against Human Neuroblastoma
Hua Fang et al.
CLINICAL CANCER RESEARCH (2011)
Targeting ATP7A to Increase the Sensitivity of Neuroblastoma Cells to Retinoid Therapy
B. B. Cheung et al.
CURRENT CANCER DRUG TARGETS (2011)
Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
Amit K. Tiwari et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
The P-glycoprotein multidrug transporter
Frances J. Sharom
ESSAYS IN BIOCHEMISTRY: ABC TRANSPORTERS (2011)
Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)
Zhanglin Ni et al.
CURRENT DRUG METABOLISM (2010)
Kinetic Analysis of the Cooperation of P-Glycoprotein (P-gp/Abcb1) and Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting the Brain and Testis Penetration of Erlotinib, Flavopiridol, and Mitoxantrone
Hiroshi Kodaira et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The Human Breast Cancer Resistance Protein (BCRP/ABCG2) Shows Conformational Changes with Mitoxantrone
Mark F. Rosenberg et al.
STRUCTURE (2010)
An Unexpected Synergist Role of P-Glycoprotein and Breast Cancer Resistance Protein on the Central Nervous System Penetration of the Tyrosine Kinase Inhibitor Lapatinib (N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine; GW572016)
Joseph W. Polli et al.
DRUG METABOLISM AND DISPOSITION (2009)
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Stephen G. Aller et al.
SCIENCE (2009)
Synthesis and evaluation of synthetic retinoid derivatives as inducers of stem cell differentiation
Victoria B. Christie et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2008)
Inhibition of MDR1 expression by retinol treatment increases sensitivity to etoposide (VP16) in human neoplasic cell line
Fabio Klamt et al.
TOXICOLOGY IN VITRO (2008)
Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid. induces down-regulation of P-glycoprotein expression and transport activity
Zdena Sulova et al.
TOXICOLOGY IN VITRO (2008)
RAR and RXR modulation in cancer and metabolic disease
Lucia Altucci et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity
Junkang Xu et al.
CANCER RESEARCH (2007)
ABCG2: determining its relevance in clinical drug resistance
Robert W. Robey et al.
CANCER AND METASTASIS REVIEWS (2007)
Anti-proliferative activity of fenretinide in human hepatoma cells in vitro and in vivo
Jianzhong Shentu et al.
ANTI-CANCER DRUGS (2007)
Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2
Christopher A. McDevitt et al.
STRUCTURE (2006)
Mechanisms of Drug Resistance in Cancer Chemotherapy
Y. A. Luqmani
MEDICAL PRINCIPLES AND PRACTICE (2005)
Novel retinoic acid derivative ABPN has potent inhibitory activity on cell growth and apoptosis in cancer cells
SJ Um et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Retinoid therapy of high-risk neuroblastoma
CP Reynolds et al.
CANCER LETTERS (2003)
The ATPases:: a new family for a family-based drug design approach
P Chène
EXPERT OPINION ON THERAPEUTIC TARGETS (2003)
Retinoic acid inhibits telomerase activity and downregulates expression but does not affect splicing of hTERT:: Correlation with cell growth rate inhibition in an in vitro cervical carcinogenesis/multidrug-resistance model
ZH Ding et al.
EXPERIMENTAL CELL RESEARCH (2002)
Inhibitors of multidrug resistance to antitumor agents (MDR)
C Avendano et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells
D Simoni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
The human ATP-binding cassette (ABC) transporter superfamily
M Dean et al.
GENOME RESEARCH (2001)
A functional-phylogenetic classification system for transmembrane solute transporters
MH Saier
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2000)
Share Paper
